Delhi: Central Bureau Of Narcotics Busts Illegal Drug Manufacturing Factory

New Delhi: The Central Bureau of Narcotics has busted an illegal drug manufacturing factory in the national capital selling Tramadol in disguise of ayurvedic medicines, the agency informed on Wednesday.

In an official statement, the agency said, “Acting on the said specific information joint Preventive team of Central Bureau of Narcotics New Delhi and Gwalior conducted a raid at Plot No. 93, Pocket G, Sector 5, Bawana Industrial Area, New Delhi and at Balaji Ayurvedic Store, Janta Bhawan Road, Sirsa (Haryana) and unearthed a clandestine Tramadol manufacturing unit at Bawana Industrial Area, New Delhi.”

Tramadol is an opioid analgesic of the same family of drugs as medications like oxycodone and hydrocodone, considering its misuse for addiction purposes Government has declared it as Psychotropic Substance in April 2018.

As per the agency, the said manufacturing unit was running in disguise of a honey processing plant and manufactured Tramadol Tablets were branded as Ayurvedic medicine.

“The search of the said premises resulted in the recovery of approx. 52.245 Kgs Tramadol pills and powder and 1.08 Kgs of substance suspected to be opium,” they said.

  • Related Posts

    Commissioner FDA reviews enforcement measures

    Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices